Investors in the healthcare sector now have a wide array of exchange-traded funds (ETFs) to consider, divided mainly into two categories: stable pharmaceutical funds and volatile biotechnology funds. A recent analysis from The Motley Fool compares popular ETFs like the State Street Health Care Select Sector SPDR ETF (XLV), known for stable, dividend-yielding holdings, and biotech-focused options like the Invesco Nasdaq Biotechnology ETF (IBBQ), which offers opportunities for higher growth but comes with considerable risk.
The analysis highlights key differences: XLV has a low expense ratio (0.08%) and a dividend yield of 1.60%, making it appealing for defensive investors. In contrast, IBBQ features a higher expense (0.19%) and a lower yield (0.80%), but aims for growth through biotech stocks. Ultimately, the best choice depends on an investor’s timeline, risk tolerance, and income needs, with traditional funds suited for those near retirement and biotech ETFs more suitable for younger investors seeking high growth.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://finance.biggo.com/news/d726c5f1-e92b-4905-b52d-a766ee8e565c
